Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0391119940030020026
Ulsan University Medical Journal
1994 Volume.3 No. 2 p.26 ~ p.32
Evaluation of Clinical Value for Determination of L-carnitine level in blood



Abstract
L-carnitine is an essential cofactor for the transport of long-chain fatty acids into mitochondria for ¥â-oxidation. Carnitine deficiencies either due to primary or secondary causes are presented as a myopathic type or systemic type like an
encephalopathy due to metabolic distrubances or even fatal cordiomyopathy. The definite diagnosis of carnitine deficiency is based on the determination of free- and acyl-carnitine concentrations in blood, urine, or various tissues and the
clinical
response to replacement of oral L-carnitine.
We reviewed 50 patients requested blood carnitine determination to evaluate diagnostic efficacy of this test. Enzymatic method with carnitine acetyltransferase and acetyl CoA as a substrate was used to determine carnitine concentration in plasma
or
serum. Normal carnitine levels were obtained from 41 control children and ranged from 7.2 mg/L (44.4¥ìmol/L) to 12.9 mg?L(79.5¥ìmol/L). Twenty-four of 50 patients had carnitine concentrations lower than 7.2 mg/L(44.4¥ìmol/L) and clinical findings
were
cardiomyopathy, congenital heart disease complicated with congestive heart failure, organic acidurias and metabolic disturbances. The clinical manifestations of patients were definitely improved in 10 patients out of 16 after treatment with
L-carnitine.
Early recognition and high dose of carnitine therapy are mainstay of carnitine deficiency. In conclusion, all patients suspected carnitine deficiency either due to primary or secondary causes should be assessed and monitored their carnitine
levels
before and after treatment.
KEYWORD
FullTexts / Linksout information
Listed journal information